GREY:CRRVF - Post by User
Comment by
buyifisell1on Dec 05, 2019 12:43pm
152 Views
Post# 30425528
RE:RE:RE:WEBSITE PRESENTATION + OVERALL CVR MED BULLBOARD
RE:RE:RE:WEBSITE PRESENTATION + OVERALL CVR MED BULLBOARD
Aquaman-
Many of us suspect that much of what Bakema did was in his personal best interest and not in the best interests of the shareholders. Work on his house? 30% loans? The structure of the deal between Global and Medical? But, there are two challenges: we don't know all of the details and, legally, a company is allowed tremendous latitude in running its business as it sees fit, no matter how clearly wrong it may be for the shareholders.
On the other hand, Bakema clearly did break the regulations in at least one case. Companies MUST notify their shareholders about news that is significant to the company. In this case, we weren't officially notified about the May 31 meeting with FDA until late August. Anything more than 2 or 3 business days would be improper. Shortly after CVR made public the news of the May meeting, I filed a complaint with the BC Securities Commision. In it, I mention the very delayed news and asked if the trading suspension would nullify the need to report promptly (I was afraid there was some way to weasel out during a CTO.). Here was their response...
"We have reviewed the information you provided in the complaint form, and appreciate you forwarding this information to us. Requirements of securities law is independent of any Cease Trade Order (CTO) issued; in other words, no, a CTO does not exempt an issuer from their obligation to file press releases disclosing material changes in the company’s business." It could be that the BCSC had something to say about Peter no longer being in charge as CEO and Chairman. Hell hath no fury like a bureaucrat scorned.